The company has started to add bearish views on Wall Street as the healthcare giant's business practices draw public scrutiny, risking its prospects, worsened by its recent leadership change. Bank of ...

This update covers the latest health sector developments, including Moderna's COVID-19 vaccine review, GSK's asthma drug FDA ...

The Centers for Disease Control and Prevention has confirmed multiple cases of the new COVID-19 variant NB.1.8.1 in the ...

The Food and Drug Administration is adjusting the standard of evidence needed for shots to be approved by the general public.

The Food and Drug Administration is implementing more rigorous standards for administering the COVID-19 vaccine and experts are worried.

Trump administration to restrict COVID vaccines to seniors and high-risk groups, pending more data for everyone else.

A Phoenix doctor weighs in on the potential impact of FDA plans to limit COVID booster access to high-risk groups, raising ...

Bartholomew County health officials said they are taking a wait-and-see approach after the Trump administration said it plans to limit approval for seasonal COVID-19 shots to seniors and others at ...

Under the new FDA guidelines, only people 65 and older and others with one or more health risk factors will be able to receive COVID-19 vaccinations. People considered healthy and under the age of 65 ...

The eye of the beholder might land on the once beautiful evening gown splattered in paint or a fabric panel with part of the ...

CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an ...

The revised version of the vaccine, marketed as Spikevax, follows FDA guidance recommending that this year’s shots target ...